AI-generated summary
The authors studied human dermal fibroblast cells treated with photobiomodulation at 660 and 810 nm, polydeoxyribonucleotide (PDRN), or both together. PDRN at 0.5 mg/mL increased cell proliferation, while photobiomodulation was associated with greater COL3A1 and ELN gene expression, and combined treatments showed no additive effect. The study used laboratory cell cultures with three replicates.
- Who or what was studied
- Human dermal fibroblasts (HFF-2 cell line) cultured in vitro
- Wavelengths
- 660, 810 nm
- Limits stated in the abstract
- The study was conducted in cultured cells with only three replicates per assay, so results may not apply to living skin or people.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 810 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.